Biomarkers of Intestinal Permeability in Metabolic Disease
Journal of Gastrointestinal and Liver Diseases · 28.05.2026 · 35 (2) · 276-285
DOI: 10.15403/jgld-6727 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, online erschienen am 28.05.2026. Verfasst von Cristina Sorina Cătană und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Fundamental Disciplines, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania. ccatana0128@gmail.com. Hauptthemen laut MEDLINE: Metabolic Diseases, Intestinal Mucosa. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Promising biomarkers of intestinal permeability in metabolic disease include lipopolysaccharide from Gram-negative bacteria and its binding proteins (soluble cluster of differentiation 14, lipopolysaccharide binding protein) and zonulin, which is associated with the transfer of microbial products into the circulation, thus leading to systemic chronic inflammation and worsening metabolic status. Occludin and intestinal-type fatty-acid binding protein are particularly increased in metabolic dysfunction-associated steatotic liver disease and cardiometabolic diseases, in which case they predict subsequent major adverse cardiovascular events and stroke. The assessment of intestinal permeability can provide information regarding the relationship between intestinal leakage and the development of certain diseases, as predictor of disease severity and treatment effectiveness. Therefore, this review aims to provide a basis for better understanding the relationship between intestinal permeability, non-invasive biomarkers, and metabolic disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Fundamental Disciplines, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania. ccatana0128@gmail.com.
- Department of Medical Education, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania. mmarta@umfcluj.ro.
- Department of Molecular Sciences, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania. denisapopa0707@yahoo.com.
- Department of Pharmaceutical Biochemistry and Clinical Laboratory, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania. cristina.craciun@umfcluj.ro.
- Department of Morphological and Functional Sciences, Iuliu Hațieganu University of Medicine and Pharmacy Cluj-Napoca, Romania. dinu.dumitrascu@umfcluj.ro.
Zitieren
APA
Cătană, C. S., Marta, M. M., Popa, D., Crăciun, E. C., & Dumitrașcu, D. I. (2026). Biomarkers of Intestinal Permeability in Metabolic Disease. Journal of Gastrointestinal and Liver Diseases, 35(2), 276-285. https://doi.org/10.15403/jgld-6727
Vancouver
Cătană CS, Marta MM, Popa D, Crăciun EC, Dumitrașcu DI. Biomarkers of Intestinal Permeability in Metabolic Disease. Journal of Gastrointestinal and Liver Diseases. 2026;35(2):276-285. doi:10.15403/jgld-6727
BibTeX
@article{Ctan2026,
author = {Cătană, Cristina Sorina and Marta, Monica Mihaela and Popa, Denisa and Crăciun, Elena Cristina and Dumitrașcu, Dinu Iuliu},
title = {Biomarkers of Intestinal Permeability in Metabolic Disease},
journal = {Journal of Gastrointestinal and Liver Diseases},
year = {2026},
volume = {35},
number = {2},
pages = {276--285},
doi = {10.15403/jgld-6727}
}
EUVIMED